Voyager Therapeutics Inc.
VYGR | NASDAQ
$3.12
+$0.04 (+1.30%)
Sep 22, 2026, 1:07 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -52.41M | -27.94M | -27.43M | -27.89M | -33.38M | -31.02M | -34.49M | -9.04M | -10.14M | -11.33M | 56.4M | -25.9M | -22.21M | 124.04M | -23.63M | 17.62M | -19.09M | -21.32M | 5.71M | -25.14M | -30.12M | -21.65M |
Depreciation & Amortization | 1.84M | 567K | 1.05M | 932K | 1.07M | 1.01M | 1.01M | 1.13M | 1.39M | 1.2M | 1.34M | 945K | 1.09M | 1.08M | 834K | 1.34M | 1.2M | 2.81M | 1.48M | 1.22M | 1.19M | 1.27M |
Stock-Based Compensation | 4.92M | 2.49M | 3.52M | 3.46M | 4.13M | 3.67M | 3.74M | 3.43M | 4.04M | 3.57M | 3.05M | 2.88M | 2.67M | 2.56M | 2.35M | 2.19M | 2.49M | 2.32M | 1.65M | 2.08M | 3.99M | 3.6M |
Other Working Capital | -11.11M | -7.78M | -11.96M | -5.69M | -1.87M | -10.52M | -1.63M | -5.76M | -21.59M | -19.87M | -872K | -962K | -1.5M | 19.8M | -3.38M | -27.38M | -678K | 49.44M | 1.91M | 620K | 586K | -7.04M |
Other Non-Cash Items | 2.07M | 1.27M | -468K | -654K | -1.96M | 253K | -1.48M | -1.87M | -518K | -815K | -1.76M | -1.79M | 72K | 27K | 384K | -25K | 2K | 21K | 25K | 111K | 1.53M | -3.78M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -15.68M | -9.81M | -6.94M | -6.89M | -3.11M | -11.81M | 16.69M | -21.62M | -26.36M | 66.14M | -82.78M | 2.82M | 17.54M | -4.14M | 7.82M | -37.34M | -605K | 50.59M | 2.33M | 1.02M | 694K | -740K |
Operating Cash Flow | -59.26M | -33.42M | -30.26M | -31.05M | -33.26M | -37.9M | -14.53M | -27.97M | -31.58M | 58.77M | -23.76M | -21.05M | -835K | 123.57M | -12.24M | -16.21M | -18.49M | 34.43M | 11.2M | -20.71M | -22.72M | -21.29M |
Capital Expenditures | -14K | -14K | -626K | -207K | -1.11M | -658K | -155K | -258K | -967K | -2.14M | -755K | -782K | -1.21M | -509K | -933K | -278K | -1.24M | -38K | -347K | -660K | -227K | -375K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 157.52M | 23.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -70.85M | -43.44M | -12.5M | -6.64M | -37.87M | -76.92M | -131.02M | -40.81M | -90.01M | -203.85M | -28.99M | -166.52M | -28.45M | n/a | n/a | n/a | -34.89M | -19.96M | -15.12M | n/a | n/a | n/a |
Sales Maturities Of Investments | 94.36M | 51.56M | 60.55M | 41.73M | 40.9M | 118.78M | 103.97M | 105.42M | 55.03M | 109.93M | 56.58M | 9M | 5M | 15M | 15M | 35M | n/a | n/a | 10M | 15M | 22.63M | 35M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -157.52M | -23.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 23.49M | 8.1M | 47.42M | 34.89M | 1.93M | 41.2M | -27.2M | 64.35M | -35.94M | -96.07M | 26.83M | -158.3M | -24.66M | 14.49M | 14.07M | 34.72M | -36.13M | -20M | -5.46M | 14.34M | 22.41M | 34.63M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 571K | 78K | 460K | 331K | 1.55M | 185K | 276K | 15K | 807K | 12K | 227K | n/a | 357K | 28K |
Financial Cash Flow | 6.24M | 3.33M | 136K | 85K | 513K | 82K | 574K | 14K | 571K | 112.86M | 460K | 331K | 1.55M | 31.31M | 276K | 15K | 807K | 12K | 227K | n/a | 357K | 28K |
Net Cash Flow | -29.53M | -21.99M | 17.3M | 1.19M | -30.82M | 3.39M | -41.16M | 36.4M | -66.95M | 75.56M | 3.53M | -179.02M | -23.95M | 169.36M | 2.1M | 18.53M | -53.54M | 14.44M | 5.96M | -6.37M | 45K | 13.36M |
Free Cash Flow | -59.28M | -33.43M | -30.89M | -31.26M | -34.37M | -38.55M | -14.68M | -28.23M | -32.55M | 56.63M | -24.52M | -21.83M | -2.05M | 123.06M | -13.18M | -16.48M | -19.73M | 34.39M | 10.85M | -21.37M | -22.94M | -21.67M |
Adj. Free Cash Flow | -64.2M | -35.92M | -34.41M | -34.72M | -38.5M | -42.23M | -18.42M | -31.66M | -36.59M | 53.05M | -27.56M | -24.71M | -4.72M | 120.5M | -15.52M | -18.67M | -22.22M | 32.07M | 9.19M | -23.45M | -26.94M | -25.27M |
Maintenance CapEx | -14K | -14K | n/a | -207K | -1.11M | -658K | -155K | n/a | n/a | -2.14M | n/a | -782K | n/a | n/a | -933K | n/a | -1.24M | -38K | n/a | -660K | -227K | -375K |
Growth CapEx | n/a | n/a | -626K | n/a | n/a | n/a | n/a | -258K | -967K | n/a | -755K | n/a | -1.21M | -509K | n/a | -278K | n/a | n/a | -347K | n/a | n/a | n/a |
Owner Earnings | -59.28M | -33.43M | -30.26M | -31.26M | -34.37M | -38.55M | -14.68M | -27.97M | -31.58M | 56.63M | -23.76M | -21.83M | -835K | 123.57M | -13.18M | -16.21M | -19.73M | 34.39M | 11.2M | -21.37M | -22.94M | -21.67M |
Add to Watchlist
Select watchlists to add or remove VYGR